LRRK2 and nonpapillary renal cell carcinoma: In conclusion, our results show that LRRK2 is expressed and up-regulated in ccRCC as identified by bioinformatics analysis and confirmed in tissue specimens, suggesting that LRRK2 may be a potential target for ccRCC treatment.